DOCUMENT METADATA

Document ID

DOC-CK-012

Version

1.0

Status

LOCKED

Authority

Clinical Knowledge Governance

Owner

Project Coordinator

Strategist

ChatGPT

Implementation

Claude

Depends On

KNOWLEDGE_POPULATION_EXECUTION_FRAMEWORK.md
CLINICAL_KNOWLEDGE_REPOSITORY_STRUCTURE.md
QUALITY_MANAGEMENT_FRAMEWORK.md
KNOWLEDGE_UPDATE_POLICY.md

Required By

Clinical Knowledge Population
Population Packages
Governance Review
Repository Integration

Last Updated

2026-08-03

1. PURPOSE

This document defines the standardized Quality Assurance (QA) framework governing all Clinical Knowledge Population activities within the Safe Medical AI System.

It establishes the quality validation layers, standardized QA checklist, quality gates, continuous quality improvement process, and traceability requirements that every Population Package shall satisfy before becoming a governed production knowledge asset.

2. DESIGN PHILOSOPHY

Knowledge Population Quality Assurance follows the principles of:

Quality before Scale
Governance before Release
Evidence Integrity
Clinical Accuracy
Continuous Improvement
Complete Traceability
Retrieval-ready by Design

Quality assurance is integrated throughout the population lifecycle rather than performed only at the end.

3. ROLE

This framework governs:

quality validation;
QA workflow;
quality gates;
continuous quality improvement;
QA traceability.

It does not define:

operational quality management;
repository organization;
evidence population;
runtime quality monitoring.
4. MULTI-LAYER QUALITY VALIDATION

Every Population Package shall undergo validation across the following quality layers:

Structural Quality

Verification of document completeness, mandatory sections, metadata integrity, and dependency consistency.

Clinical Quality

Verification of clinical correctness, terminology consistency, and patient-centered communication.

Evidence Quality

Verification of evidence provenance, hierarchy, synthesis integrity, and approved evidence sources.

Governance Quality

Verification of governance compliance, lifecycle status, approval records, and policy adherence.

Retrieval Readiness

Verification that the Population Package is complete, internally linked,
structurally suitable for repository integration, and prepared for downstream
retrieval.

Retrieval Readiness confirms package-level readiness.

It does not constitute repository integration verification.

Repository integration, exact path resolution, registry linkage, immutable
repository evidence, and aggregate integration status are verified separately
under the Phase 4 Repository & Integration Verification process.

All quality validation layers must be successfully completed before a
Population Package may proceed to repository integration verification.

5. STANDARD QA CHECKLIST

Every Population Package shall be evaluated using a standardized QA checklist.

Minimum validation items include:

Structural completeness
Evidence traceability
Clinical accuracy
Patient readability
Internal consistency
Relationship integrity
Metadata completeness
Governance compliance

Additional validation items may be introduced through governed amendments without altering the core framework.

6. QUALITY GATE POLICY

Every Population Package shall receive one of the following quality outcomes:

PASS

All validation requirements satisfied.

The Population Package may proceed to repository integration.

CONDITIONAL PASS

Minor deficiencies identified.

Repository integration is deferred until required amendments have been completed and verified.

FAIL

Major deficiencies identified.

The Population Package returns to the Population Execution Workflow for correction before any further governance review.

No Population Package may bypass the Quality Gate.

7. CONTINUOUS QUALITY IMPROVEMENT

Quality assurance continues throughout the lifecycle of every Population Package.

Quality reassessment shall be initiated following:

publication of updated clinical guidelines;
approval of higher-level evidence;
governance amendments;
safety-related findings;
scheduled quality reviews.

Every reassessment shall preserve governance traceability and amendment history.

8. QUALITY TRACEABILITY

Every QA activity shall be explicitly documented.

Quality records shall remain linked to:

Population Package;
Clinical Knowledge Object;
Knowledge Passport;
Primary Evidence Package.

Traceability shall support governance review, auditing, and continuous organizational learning.

9. GOVERNANCE PRINCIPLES

Knowledge Population Quality Assurance shall maintain:

standardized validation;
reproducible review;
transparent decision-making;
explicit approval records;
complete auditability;
continuous governance compliance.

Quality governance shall prioritize patient safety over production throughput.

10. QUALITY REQUIREMENTS

Before approval, every Population Package shall satisfy:

successful multi-layer validation;
standardized QA checklist completion;
PASS or resolved CONDITIONAL PASS status;
complete QA documentation;
traceable review records;
governance approval.

Only validated Population Packages may enter the governed Clinical Knowledge Repository.

11. RELATED DOCUMENTS
Upstream
KNOWLEDGE_POPULATION_EXECUTION_FRAMEWORK.md
CLINICAL_KNOWLEDGE_REPOSITORY_STRUCTURE.md
QUALITY_MANAGEMENT_FRAMEWORK.md
KNOWLEDGE_UPDATE_POLICY.md
Downstream
Population Packages
Knowledge Registry
Retrieval-ready Repository
Governance Audit
Clinical Validation Records
12. AMENDMENT TRACEABILITY
Version 1.0

Initial Phase 3 release.

Integrated Locked Decisions:

LD-0411 — Multi-layer Quality Validation
LD-0412 — Standard QA Checklist
LD-0413 — Quality Gate Policy
LD-0414 — Continuous Quality Improvement
LD-0415 — Quality Traceability

This document establishes the Quality Assurance framework governing Clinical Knowledge Population and standardizes quality validation, approval, and continuous improvement across all Population Packages.